Dentsply Sirona (NSDQ:XRAY) posted third-quarter results this week that beat the overall consensus on Wall Street.
The Charlotte, N.C.-based company reported profits of $103 million, or 47¢ per share, on sales of $1.07 billion for the three months ended September 30, for a bottom-line gain of 94.3% on sales growth of 19.44% compared with Q3 2020.
Adjusted to exclude one-time items, earnings per share were 68¢, 3¢ ahead of The Street where analysts were looking for sales of $1.03 billion.
“In the third quarter, we delivered strong results in an environment still impacted by the pandemic. Organic sales grew over 21%, driven by continued recovery in the dental market and robust demand from our recent product launches. Our teams have also done a commendable job navigating supply chain bottlenecks to deliver products to our customers,” CEO Don Casey said in a news release. “In the quarter, we continued to accelerate investments in new products and software that will drive both short and long-term growth.”
Dentsply Sirona said it is “tightening” its revenue range to be in the range of $4.25 billion to $4.3 billion to represent a 27-30% growth in FY 2021. Non-GAAP EPS for the full year is expected to be in the range of $2.87 to $2.92.
Shares in XRAY were up 1.13% to $59.89 apiece in pre-market trading.